Original Research
Accepted on 18 Aug 2025
Efficacy and Safety of DEB-TACE Combined with Transarterial TQB2450 Infusion and Oral Anlotinib as first-line treatment in Advanced Hepatocellular Carcinoma: A Single-Arm Phase II Study
in Cancer Immunity and Immunotherapy